Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesInvestors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Red Cat Holdings posted a record Q4 revenue of $26.2 million and full-year $40.7 million, but margins stayed thin and...
Amazon faces a pullback even as cloud, ads, and silicon efforts pick up speed. Analysts see roughly 36% upside over t...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...
A rally in Cava lifted the restaurant group, but Sweetgreen’s disappointing sales offer pulled markets back, undersco...
Bitcoin jumped to a three-month high Friday as traders locked in gains. CryptoQuant data show a surge in realized pro...
Geopolitical moves from the July U.S. strike on Iran sent shockwaves through crypto markets as Bitcoin and Ethereum p...
A QuidelOrtho Corp director purchases 10,000 shares amid a CFO retirement, sparking investor interest. This article e...
Apple signals a strategic pivot, moving its flagship away from the iPhone toward ambient computing with Vision Pro an...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...